These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2702992)

  • 1. A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder.
    Blackledge G; Roberts JT; Kaye S; Taylor R; Williams J; de Stavola B; Uscinska B
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):391-2. PubMed ID: 2702992
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II evaluation of mitozolomide in ovarian cancer.
    Harding M; Northcott D; Smyth J; Stuart NS; Green JA; Newlands E
    Br J Cancer; 1988 Jan; 57(1):113-4. PubMed ID: 3348943
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867.
    Fosså SD; Splinter T; Roozendaal KJ; Veenhof KH; Pavone-Macaluso M; Calciati A; de Pauw M; Sylvester R
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):389-90. PubMed ID: 2702991
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group.
    Somers R; Santoro A; Verweij J; Lucas P; Rouëssé J; Kok T; Casali A; Seynaeve C; Thomas D
    Eur J Cancer; 1992; 28A(4-5):855-7. PubMed ID: 1524907
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of the urinary bladder.
    Raabe NK; Fossa SD; Parø G
    Br J Urol; 1989 Dec; 64(6):604-7. PubMed ID: 2697452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
    van Oosterom AT; Stoter G; Bono AV; Splinter TA; Fossa SD; Verbaeys AJ; de Mulder PH; de Pauw M; Sylvester R
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1249-50. PubMed ID: 2767112
    [No Abstract]   [Full Text] [Related]  

  • 7. Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities.
    Einstein AB; Shipley W; Coombs J; Cummings KB; Soloway MS; Hawkins I
    Urology; 1984 Apr; 23(4 Suppl):110-7. PubMed ID: 6538712
    [No Abstract]   [Full Text] [Related]  

  • 8. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux].
    Rampal M; Alimi JC; Pons G; Fiquet JM
    J Urol Nephrol (Paris); 1978 Mar; 84(3):271-4. PubMed ID: 417193
    [No Abstract]   [Full Text] [Related]  

  • 9. A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder (a report of the Medical Research Council Working Party on Urological Cancer, Subgroup in Advanced Bladder Cancer).
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):375-7. PubMed ID: 3301367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abbreviated phase I clinical trial of i.v. mitozolomide.
    Joss RA; Ryssel HJ; Bischoff AK; Goldhirsch A; Brunner KW
    Cancer Treat Rep; 1986 Jun; 70(6):797-8. PubMed ID: 3524827
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of mitozolomide in patients with advanced ovarian cancer. A study of the EORTC Gynecological Cancer Cooperative Group.
    Neijt JP; van der Burg ME; Guastalla JP; George M; Piccart M; Vermorken J; Carnino F; Rotmensz N
    Acta Oncol; 1989; 28(5):663-5. PubMed ID: 2590542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of mitozolomide (M & B 39,565) in head and neck cancer.
    Herait P; Armand JP; Benahmed M; Domenge C; Fontana X; Recondo G; Cvitkovic E; Delgado FM
    Med Oncol Tumor Pharmacother; 1989; 6(4):267-9. PubMed ID: 2615530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of mitozolomide (M & B 39,565) in colorectal and breast cancer.
    Herait P; Rougier P; Oliveira J; Delgado FM; May-Levin F; Hayat M; Armand JP
    Invest New Drugs; 1988 Dec; 6(4):323-5. PubMed ID: 3229944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase II trial of TCNU versus mitozolomide in malignant melanoma. EORTC Early Clinical Trials Group.
    Smyth JF; Gundersen S; Renard J; Pinedo HM
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):755-7. PubMed ID: 2714350
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylglyoxal bis-guanylhydrazone in advanced bladder cancer.
    Von Hoff DD; Blumenstein BA; Pollock TW; Crawford ED; Weick JK; Guy JT; Eisenberger M; Fletcher WS; Natale RB
    Eur J Cancer; 1990; 26(7):848-9. PubMed ID: 2145912
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.
    Rodriguez LH; Johnson DE; Holoye PY; Samuels ML
    Cancer Treat Rep; 1977; 61(1):87-8. PubMed ID: 324624
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase I clinical trial of mitozolomide.
    Newlands ES; Blackledge G; Slack JA; Goddard C; Brindley CJ; Holden L; Stevens MF
    Cancer Treat Rep; 1985; 69(7-8):801-5. PubMed ID: 4016790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of everolimus in metastatic urothelial cancer.
    Smith AB; Pruthi RS
    BJU Int; 2013 Aug; 112(4):427-8. PubMed ID: 23879903
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease.
    Gundersen S; Aamdal S; Fodstad O
    Br J Cancer; 1987 Apr; 55(4):433-5. PubMed ID: 3580266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Sacks P; Jacobs P; Gale D; Lynch SR; Bothwell TH; Stevens K
    S Afr Med J; 1973 Jun; 47(21):903-7. PubMed ID: 4351107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.